Correlation Between Plandai Biotech and Direct Communication

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Plandai Biotech and Direct Communication at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Plandai Biotech and Direct Communication into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Plandai Biotech and Direct Communication Solutions, you can compare the effects of market volatilities on Plandai Biotech and Direct Communication and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Plandai Biotech with a short position of Direct Communication. Check out your portfolio center. Please also check ongoing floating volatility patterns of Plandai Biotech and Direct Communication.

Diversification Opportunities for Plandai Biotech and Direct Communication

0.15
  Correlation Coefficient

Average diversification

The 3 months correlation between Plandai and Direct is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Plandai Biotech and Direct Communication Solutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Direct Communication and Plandai Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Plandai Biotech are associated (or correlated) with Direct Communication. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Direct Communication has no effect on the direction of Plandai Biotech i.e., Plandai Biotech and Direct Communication go up and down completely randomly.

Pair Corralation between Plandai Biotech and Direct Communication

Given the investment horizon of 90 days Plandai Biotech is expected to generate 7.61 times more return on investment than Direct Communication. However, Plandai Biotech is 7.61 times more volatile than Direct Communication Solutions. It trades about 0.17 of its potential returns per unit of risk. Direct Communication Solutions is currently generating about 0.16 per unit of risk. If you would invest  0.04  in Plandai Biotech on September 3, 2024 and sell it today you would lose (0.02) from holding Plandai Biotech or give up 50.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Plandai Biotech  vs.  Direct Communication Solutions

 Performance 
       Timeline  
Plandai Biotech 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Plandai Biotech are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating basic indicators, Plandai Biotech disclosed solid returns over the last few months and may actually be approaching a breakup point.
Direct Communication 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Direct Communication Solutions has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Direct Communication is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Plandai Biotech and Direct Communication Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Plandai Biotech and Direct Communication

The main advantage of trading using opposite Plandai Biotech and Direct Communication positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Plandai Biotech position performs unexpectedly, Direct Communication can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Direct Communication will offset losses from the drop in Direct Communication's long position.
The idea behind Plandai Biotech and Direct Communication Solutions pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories